Dr. Schmidt is a mass spectrometrist with over 30 years experience in separations, quantitative methods and pharmacokinetics. At the University of Iowa, he performed work that was foundational in the approval of novel antimalarial drugs and optimized quantitative NAD metabolomics for the first human clinical study of NR.
Dr. Brenner is the discoverer of the eukaryotic nicotinamide riboside (NR) kinase pathway to nicotinamide adenine dinucleotide (NAD). He combines a deep understanding of human metabolism with advanced techniques in enzymology, genetics, genomics, high throughput screening, and quantitative mass spectrometry. He earned his PhD at Stanford and did post-doctoral work at Brandeis before holding faculty positions at Jefferson, Dartmouth and Iowa. He serves as the Roy J. Carver Chair and Head of Biochemistry and Professor of Internal Medicine, and is a Founding Director of the University of Iowa Obesity Research & Education Initiative.
Copyright © NRomics, LLC. All rights reserved